56 Participants Needed

Acetabular Shell Revision for Hip Arthritis

(RAS Trial)

SJ
SC
MP
Overseen ByMarissa Puccio
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This study will be a non-randomized, ambidirectional (retrospective and prospective) study where all subjects will be followed prospectively. The study will evaluate the survivorship of the RAS acetabular component in a previously failed total hip arthroplasty (THA) in a consecutive series of subjects who meet the eligibility criteria.

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify if you need to stop taking your current medications. However, if you are receiving steroids in excess of normal physiological requirements, you may be excluded from the trial.

What data supports the idea that Acetabular Shell Revision for Hip Arthritis is an effective treatment?

The available research does not directly address the effectiveness of Acetabular Shell Revision for Hip Arthritis specifically. However, it does discuss various techniques for dealing with severe bone loss in hip surgeries, which is a related issue. For instance, one study mentions a new acetabular shell that helps maintain the natural position of the hip joint, which is important for good movement and stability. Another study talks about using a 'double-cup' method to handle severe bone defects, which could be similar to the challenges faced in hip arthritis cases. These studies suggest that innovative approaches in hip surgeries can lead to better outcomes, but they don't provide specific data on Acetabular Shell Revision for Hip Arthritis itself.12345

What safety data exists for acetabular shell revision treatments like the Trident and Trident II systems?

Safety data for the Trident acetabular system indicates issues with incomplete seating of metal-backed ceramic liners, with a reported incidence of 16.4% in one study and 8% in another. Shell deformation may contribute to this problem. For the Trident II system, there have been reports of screw/shell interface failures, suggesting potential design flaws. These findings highlight technical challenges and the need for careful surgical technique to mitigate risks.16789

Is the Restoration Anatomic Acetabular Shell a promising treatment for hip arthritis?

The Restoration Anatomic Acetabular Shell is a promising treatment for hip arthritis because it is designed to improve the fit and function of hip replacements, potentially leading to better movement and comfort for patients.1011121314

Eligibility Criteria

This trial is for individuals needing a revision of a failed hip replacement component, specifically with the Restoration Anatomic Acetabular Shell. Participants must be adults who can follow post-op check-ups and have signed an informed consent form. Those with extreme obesity (BMI > 45), infections around the hip, immune suppression, mental or neuromuscular issues affecting recovery, poor bone quality, or sensitivity to device materials cannot join.

Inclusion Criteria

I am a man or a woman not currently pregnant.
I am a candidate for hip socket revision surgery.
Subject is willing and able to comply with postoperative scheduled clinical evaluations
See 2 more

Exclusion Criteria

I have a condition like Lupus or Paget's Disease affecting my bones.
Subject has a mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care
I am on long-term steroids or have a weakened immune system.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Restoration Anatomic Acetabular Shell as part of the revision surgery for failed total hip arthroplasty

Surgical procedure

Follow-up

Participants are monitored for safety and effectiveness after treatment, including evaluation of adverse events and success rate

10 years

Treatment Details

Interventions

  • Restoration Anatomic Acetabular Shell
Trial OverviewThe study is testing the long-term effectiveness ('survivorship') of the RAS acetabular shell in patients whose previous total hip arthroplasty has failed. It's a non-randomized study tracking patients both retrospectively and prospectively after they receive this specific implant.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Restoration Anatomic Acetabular ShellExperimental Treatment1 Intervention

Restoration Anatomic Acetabular Shell is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Restoration Anatomic Shell for:
  • Revision of previously failed total hip arthroplasty (THA)
  • Primary and revision procedures for degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis, or late stage avascular necrosis
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Trident II Acetabular Shell for:
  • Revision of previously failed total hip arthroplasty (THA)
  • Primary and revision procedures for degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis, or late stage avascular necrosis

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stryker Orthopaedics

Lead Sponsor

Trials
79
Recruited
20,500+

Kevin A. Lobo

Stryker Orthopaedics

Chief Executive Officer since 2012

Bachelor's degree in Commerce from McGill University, MBA from University of Toronto

Dr. Jorge Enrique Diaz

Stryker Orthopaedics

Chief Medical Officer since 2023

MD from University of Michigan Medical School

Findings from Research

In a study of 41 patients with massive acetabular bone loss, the use of an antiprotrusio cage combined with porous metal augments showed an 87.4% survival rate free from aseptic cage failure at 10 years, indicating good long-term efficacy of this reconstruction technique.
Patients experienced a significant reduction in their need for ambulatory aids after surgery, suggesting improved functional outcomes following the procedure.
Hip Arthroplasty With the Use of a Reconstruction Cage and Porous Metal Augment to Treat Massive Acetabular Bone Loss: A Midterm Follow-Up.Garceau, SP., Warschawski, Y., Joly, D., et al.[2022]
The novel double-cup construct using a Trabecular Metal Revision Shell for treating Paprosky type IIIA and IIIB acetabular defects showed no cases of acetabular loosening in a study of 20 patients over a mean follow-up of 2.4 years.
While the technique demonstrated significant improvements in hip function, with average Harris Hip Scores rising from 28.2 to 68.7, a 25% dislocation rate was noted, primarily occurring within the first year post-surgery.
The Double-Cup Construct: A Novel Treatment Strategy for the Management of Paprosky IIIA and IIIB Acetabular Defects.Webb, JE., McGill, RJ., Palumbo, BT., et al.[2018]
The new acetabular shell is designed to maintain the native hip center-of-rotation (COR) while providing effective fixation during revision total hip arthroplasty (THA), particularly in cases with significant acetabular bone loss.
This case series highlights the shell's potential to successfully lower the hip COR in challenging revision THA scenarios, suggesting it may improve surgical outcomes for patients with severe bone loss.
Difficult Revision Total Hip Arthroplasty Cases Treated with an Offset Head Center Acetabular Shell.Wassef, A., Sodhi, N., Khlopas, A., et al.[2019]

References

Hip Arthroplasty With the Use of a Reconstruction Cage and Porous Metal Augment to Treat Massive Acetabular Bone Loss: A Midterm Follow-Up. [2022]
The Double-Cup Construct: A Novel Treatment Strategy for the Management of Paprosky IIIA and IIIB Acetabular Defects. [2018]
Difficult Revision Total Hip Arthroplasty Cases Treated with an Offset Head Center Acetabular Shell. [2019]
The use of customized cages in revision total hip arthroplasty for Paprosky type III acetabular bone defects. [2018]
Survivorship of polyethylene liner exchanges performed for the treatment of wear and osteolysis among porous-coated cups. [2022]
Incomplete seating of the liner with the Trident acetabular system: a cause for concern? [2016]
Seating of ceramic liners in the uncemented trident acetabular shell: is there really a problem? [2021]
Failure of Screw/Shell Interface in the Trident II Acetabular System in Total Hip Arthroplasty. [2022]
Outcome of cages in revision arthroplasty of the acetabulum: a systematic review. [2020]
[Use of the CEREC system in dental practices. Esthetic reconstruction of the anterior teeth--a case report]. [2016]
CAD-CAM natural restorations-Reproducing nature using a digital workflow. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
The Effect of Implant Abutment Design on Long-Term Soft Tissue Stability: A Clinical Case Report. [2019]
[Rehabilitation of the anterior portions of the maxilla and mandible by means of implants and bone grafts]. [2011]
14.United Statespubmed.ncbi.nlm.nih.gov
Rebuilding core foundations for existing crowns using a custom-made template. [2005]